| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Department of Otolaryngology, Head and Neck Surgery, Division of Head and Neck Cancer Research [P. P., Y. X., M. S-C., D. C., D. S.] and Department of Pathology [T. N., E. G.] Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.; Virco Lab, Inc., Johns Hopkins Bayview Research Campus, Baltimore, Maryland 21224 [M. F., S. P., M. S.]; Laboratory for Molecular Medicine and Biotechnology and Department of Pathology [C. R.], Università Campus Bio-Medico, 00155 Rome, Italy [P. M., M. R., C. C., V. M. F.]; IRCCS H. "Casa Sollievo della Sofferenza," 71013 San Giovanni Rotondo, FO66IA [V. M. F.], Italy
To determine the frequency and distribution of mitochondrial DNA mutations in breast cancer, 18 primary breast tumors were analyzed by direct sequencing. Twelve somatic mutations not present in matched lymphocytes and normal breast tissues were detected in 11 of the tumors screened (61%). Of these mutations, five (42%) were deletions or insertions in a homopolymeric C-stretch between nucleotides 303315 (D310) within the D-loop. The remaining seven mutations (58%) were single-base substitutions in the coding (ND1, ND4, ND5, and cytochrome b genes) or noncoding regions (D-loop) of the mitochondrial genome. In three cases (25%), the mutations detected in coding regions led to amino acid substitutions in the protein sequence. We then screened an additional 46 primary breast tumors with a rapid PCR-based assay to identify poly-C alterations in D310, and we found seven more cancers with alterations. Using D310 mutations as clonal marker, we detected identical changes in five of five matched fine-needle aspirates and in four of four metastases-positive lymph nodes. The high frequency of D310 alterations in primary breast cancer combined with the high sensitivity of the PCR-based assays provides a new molecular tool for cancer detection.
This article has been cited by other articles:
![]() |
S. Dasgupta, M. O. Hoque, S. Upadhyay, and D. Sidransky Mitochondrial Cytochrome B Gene Mutation Promotes Tumor Growth in Bladder Cancer Cancer Res., February 1, 2008; 68(3): 700 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gasparre, A. M. Porcelli, E. Bonora, L. F. Pennisi, M. Toller, L. Iommarini, A. Ghelli, M. Moretti, C. M. Betts, G. N. Martinelli, et al. Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors PNAS, May 22, 2007; 104(21): 9001 - 9006. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guha, S. Srinivasan, G. Biswas, and N. G. Avadhani Activation of a Novel Calcineurin-mediated Insulin-like Growth Factor-1 Receptor Pathway, Altered Metabolism, and Tumor Cell Invasion in Cells Subjected to Mitochondrial Respiratory Stress J. Biol. Chem., May 11, 2007; 282(19): 14536 - 14546. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, F. F. Kadlubar, and J. Z. Chen DNA supercoiling suppresses real-time PCR: a new approach to the quantification of mitochondrial DNA damage and repair Nucleic Acids Res., March 13, 2007; (2007) gkm010v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhou, K. Kassauei, D. J. Cutler, G. C. Kennedy, D. Sidransky, A. Maitra, and J. Califano An Oligonucleotide Microarray for High-Throughput Sequencing of the Mitochondrial Genome J. Mol. Diagn., September 1, 2006; 8(4): 476 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Isidoro, E. Casado, A. Redondo, P. Acebo, E. Espinosa, A. M. Alonso, P. Cejas, D. Hardisson, J. A. Fresno Vara, C. Belda-Iniesta, et al. Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis Carcinogenesis, December 1, 2005; 26(12): 2095 - 2104. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lievre, C. Chapusot, A.-M. Bouvier, F. Zinzindohoue, F. Piard, P. Roignot, L. Arnould, P. Beaune, J. Faivre, and P. Laurent-Puig Clinical Value of Mitochondrial Mutations in Colorectal Cancer J. Clin. Oncol., May 20, 2005; 23(15): 3517 - 3525. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Jakupciak, W. Wang, M. E. Markowitz, D. Ally, M. Coble, S. Srivastava, A. Maitra, P. E. Barker, D. Sidransky, and C. D. O'Connell Mitochondrial DNA as a Cancer Biomarker J. Mol. Diagn., May 1, 2005; 7(2): 258 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shidara, K. Yamagata, T. Kanamori, K. Nakano, J. Q. Kwong, G. Manfredi, H. Oda, and S. Ohta Positive Contribution of Pathogenic Mutations in the Mitochondrial Genome to the Promotion of Cancer by Prevention from Apoptosis Cancer Res., March 1, 2005; 65(5): 1655 - 1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Coene, M. S. Hollinshead, A. A.T. Waeytens, V. R.J. Schelfhout, W. P. Eechaute, M. K. Shaw, P. M.V. Van Oostveldt, and D. J. Vaux Phosphorylated BRCA1 Is Predominantly Located in the Nucleus and Mitochondria Mol. Biol. Cell, February 1, 2005; 16(2): 997 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.C. WALLACE Mitochondria and Cancer: Warburg Addressed Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 363 - 374. [Abstract] [PDF] |
||||
![]() |
W. Zhu, W. Qin, P. Bradley, A. Wessel, C. L. Puckett, and E. R. Sauter Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid Carcinogenesis, January 1, 2005; 26(1): 145 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Parrella, M. L. Poeta, A. P. Gallo, M. Prencipe, M. Scintu, A. Apicella, R. Rossiello, G. Liguoro, D. Seripa, C. Gravina, et al. Nonrandom Distribution of Aberrant Promoter Methylation of Cancer-Related Genes in Sporadic Breast Tumors Clin. Cancer Res., August 15, 2004; 10(16): 5349 - 5354. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maitra, Y. Cohen, S. E.D. Gillespie, E. Mambo, N. Fukushima, M. O. Hoque, N. Shah, M. Goggins, J. Califano, D. Sidransky, et al. The Human MitoChip: A High-Throughput Sequencing Microarray for Mitochondrial Mutation Detection Genome Res., May 1, 2004; 14(5): 812 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
L-J C Wong, D-J Tan, R-K Bai, K-T Yeh, and J Chang Molecular alterations in mitochondrial DNA of hepatocellular carcinomas: is there a correlation with clinicopathological profile? J. Med. Genet., May 1, 2004; 41(5): e65 - e65. [Full Text] [PDF] |
||||
![]() |
R. Lehtonen, M. Kiuru, S. Vanharanta, J. Sjoberg, L.-M. Aaltonen, K. Aittomaki, J. Arola, R. Butzow, C. Eng, K. Husgafvel-Pursiainen, et al. Biallelic Inactivation of Fumarate Hydratase (FH) Occurs in Nonsyndromic Uterine Leiomyomas but Is Rare in Other Tumors Am. J. Pathol., January 1, 2004; 164(1): 17 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Li, M. Cuilleron, A. Gentil-Perret, M. Cottier, K. Passebosc-Faure, C. Lambert, C. Genin, and J. Tostain Rapid and Sensitive Detection of Messenger RNA Expression for Molecular Differential Diagnosis of Renal Cell Carcinoma Clin. Cancer Res., December 15, 2003; 9(17): 6441 - 6446. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suzuki, S. Toyooka, K. Miyajima, T. Iizasa, T. Fujisawa, N. B. Bekele, and A. F. Gazdar Alterations in the Mitochondrial Displacement Loop in Lung Cancers Clin. Cancer Res., November 15, 2003; 9(15): 5636 - 5641. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Z. Chen, N. Gokden, G. F. Greene, B. Green, and F. F. Kadlubar Simultaneous generation of multiple mitochondrial DNA mutations in human prostate tumors suggests mitochondrial hyper-mutagenesis Carcinogenesis, September 1, 2003; 24(9): 1481 - 1487. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Okochi, K. Hibi, T. Uemura, S. Inoue, S. Takeda, T. Kaneko, and A. Nakao Detection of Mitochondrial DNA Alterations in the Serum of Hepatocellular Carcinoma Patients Clin. Cancer Res., September 1, 2002; 8(9): 2875 - 2878. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Dong and D. Sidransky Absence of ST7 Gene Alterations in Human Cancer Clin. Cancer Res., September 1, 2002; 8(9): 2939 - 2941. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mambo, S. G. Nyaga, V. A. Bohr, and M. K. Evans Defective Repair of 8-Hydroxyguanine in Mitochondria of MCF-7 and MDA-MB-468 Human Breast Cancer Cell Lines Cancer Res., March 1, 2002; 62(5): 1349 - 1355. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |